Neuroepidemiologists specialize in studying the distribution, determinants, and risk factors of neurological disorders within populations. Their work involves identifying patterns and causes of conditions such as stroke, epilepsy, multiple sclerosis, Parkinson’s disease, and neurodegenerative disorders across different demographic and geographic groups. By analyzing large-scale data sets, conducting cohort and case-control studies, and performing longitudinal surveillance, they uncover associations between genetics, environment, lifestyle, and neurological disease burden. These insights contribute to improved public health interventions and targeted prevention strategies for at-risk populations.
In collaboration with neurologists, public health professionals, biostatisticians, and policymakers, neuroepidemiologists translate epidemiological evidence into actionable health recommendations and clinical guidelines. They contribute to global health initiatives by monitoring neurological disease trends, tracking outbreaks of infections that affect the brain (such as Zika or Japanese encephalitis), and evaluating the impact of health policies on neurological outcomes. Their expertise is essential in assessing healthcare access, disparities in neurological care, and population-level effectiveness of interventions. Many also investigate the neurological effects of environmental toxins, occupational hazards, and aging. As neurological disorders continue to rise globally, neuroepidemiologists play a critical role in shaping effective, data-driven responses to reduce the burden of brain-related diseases and improve quality of life for millions.
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom